Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
SCYNEXIS, Inc. - First Candidate from SCYNEXIS’ Novel Cyclophilin Inhibitor Platform, SCY-635, Establishes Proof of Concept in HCV-Infected Adults
Angiogenesis - Research data from University of Michigan update understanding of angiogenesis
Cancer - Findings from A. Kuemmerle et al in cancer reported
Cancer - New cancer research from Catholic University discussed
Colon Cancer - Research from T. Cartwright and co-authors yields new data on colon cancer
Gastric Cancer - Reports outline gastric cancer study findings from S. Inada and colleagues
Gastric Cancer - Reports outline gastric cancer study results from Fudan University
Gastric Cancer - Researchers from University of Glasgow report on findings in gastric cancer
Gastrointestinal Stromal Tumors - New findings from M.C. Heinrich and co-authors describe advances in gastrointestinal stromal tumors
Gene Therapy - Researchers at University of Milan target gene therapy
Glioblastoma - Data on glioblastoma discussed by K.A. Smith and colleagues
Glioblastoma - New glioblastoma study findings have been reported by scientists at Duke University, Brain Tumor Center
Glioblastoma - Research results from Mayo Clinic update knowledge of glioblastoma
Monoclonal Antibodies - Reports outline monoclonal antibodies study results from Leiden University
Monoclonal Antibodies - Research on monoclonal antibodies described by S.P. Treon and colleagues
Non-Small Cell Lung Cancer - New non-small cell lung cancer study findings have been reported by A. Passardi and co-researchers
Non-Small Cell Lung Cancer - Research from J.V. Heymach and colleagues has provided new data on non-small cell lung cancer
Pancreatic Cancer - Recent findings from C. Morizane and co-authors highlight research in pancreatic cancer
Pharmacokinetics - Research conducted at Johns Hopkins University has provided new information about pharmacokinetics
Prostate Cancer - Researchers from Oregon Health & Science University discuss findings in prostate cancer
Renal Cell Carcinoma - Scientists at University of New Mexico target renal cell carcinoma
Small Cell Lung Cancer - Research conducted at Tohoku University has provided new information about small cell lung cancer
Solid Cancer - Findings in solid cancer reported from University of Freiburg
Surgery - Study data from Duke University update knowledge of surgery
Lupus Therapy - New lupus therapy study findings have been published by S. Muller and colleagues
Achaogen - Achaogen Receives £4.1 Million Award from the Wellcome Trust to Advance Its Neoglycosides Portfolio
Advaxis Inc - Advaxis’ Phase II Clinical Trial “HOLD” Lifted
Allergies - Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
Altus Pharmaceuticals - Altus Pharmaceuticals Successfully Completes Phase 1 Study of Long Acting Formulation of Recombinant Human Growth Hormone
Array BioPharma Inc. - Array BioPharma Initiates Phase 1 Clinical Trial for MEK Inhibitor ARRY-300
Arthritis - Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients
AVEO Pharmaceuticals, Inc. - AVEO Pharmaceuticals to Present at 27th Annual J.P. Morgan Healthcare Conference
Cancer Vaccines - ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
Delayed Graft Function - Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Depomed, Inc. - Depomed’s License Agreement With Solvay Pharmaceuticals Clears HSR Review
Drug Resistance - Galderma Announces Availability of Epiduo Gel, the First and Only Combination Treatment With a Retinoid and Benzoyl Peroxide To Treat Acne
Enzyme Research - Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
Erectile Dysfunction - Warner Chilcott and Dong-A Sign U.S. License Agreement for Erectile Dysfunction Treatment
ESBATech Ag - ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity
Genta Incorporated - Genta Summarizes Phase 2 Activity and Receives Orphan Drug Designation in Gastric Cancer for Tesetaxel, a Leading Oral Taxane in Clinical Development
Hepatitis C Virus - ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
KYTHERA Biopharmaceuticals, Inc. - KYTHERA Biopharmaceuticals Announces Positive Results from Two Phase 2 Studies with ATX-101 Demonstrating Reduction of Submental Fat
Leukemia - The Leukemia & Lymphoma Society and the University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
Lupus Nephritis - BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
Neurogenic Bladder - Tengion to Present at 27th Annual JP Morgan Healthcare Conference
Non-Small Cell Lung Cancer - Aegera Therapeutics Initiates a Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
Plexxikon Inc. and Roche - Plexxikon and Roche Enter Second Partnership to Develop PLX5568 for Polycystic Kidney Disease
